Clinical Trials
20 trialsCAR-T Followed by Bispecific Antibodies
Abramson Cancer Center at Penn Medicine
A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Glofitamab in Chinese Patients With R/R DLBCL
Peking Union Medical College Hospital
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Virginia Commonwealth University
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
ODIN
University Health Network, Toronto
Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
The First Affiliated Hospital of Soochow University
Q702 for the Treatment of Patients With Hematologic Malignancies
Mayo Clinic
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Memorial Sloan Kettering Cancer Center
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Florida International University
Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL
Ain Shams University
Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
The First Affiliated Hospital with Nanjing Medical University
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
The First Affiliated Hospital of Xiamen University
AZA Combined With RCHOP in P53-mutated DLBCL.
The First Affiliated Hospital of Xiamen University
Real-World Study of DLBCL With Different Genetic Subtypes
Ruijin Hospital
HOVON161
University Medical Center Groningen
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
Zhejiang Provincial People's Hospital
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
University Medical Center Goettingen
Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
Australasian Leukaemia and Lymphoma Group